ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
COVID vaccines

Vietnamese COVID vaccine goes to final trial, as Hanoi lags on shots

Shunning Chinese options adds pressure to domestic push for inoculation

The Military Medical Academy deployed phase 2 of the test injection of Nanocovax vaccine to prevent COVID-19. (Photo courtesy of  the Military Medical Academy)

HANOI -- Vietnam's first coronavirus vaccine candidate is headed for a final-stage trial, giving a country that has accepted no Chinese-made shots a chance to gain ground on Southeast Asian peers in inoculating its people.

Nanocovax, a recombinant protein vaccine made using animal cells, was developed by a startup called Nanogen Pharmaceutical Biotechnology in collaboration with Vietnam Military Medical University. The first-phase trial began in December, followed by the start of the second phase in late February.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more